Mone F, et al. - The authors aimed at assessing the impact of low dose aspirin (LDA) use on preeclampsia biomarkers and fetal growth in low-risk women. In low-risk nulliparous women, low dose aspirin seemed to promote fetal growth between the first and second trimester, which is not evident thereafter. No impact of aspirin on placental or systemic biomarkers assessed was demonstrated here.